Intellia Therapeutics Names Graeme Bell Chief Financial Officer
Go back to Intellia Therapeutics Names Graeme Bell Chief Financial Officer| (NASDAQ: NTLA) | Delayed: 12.69 +0.47 (3.85%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.22 | 52 Week High | $30.40 | |||
| Open | $12.27 | 52 Week Low | $11.86 | |||
| Day High | $12.97 | P/E | N/A | |||
| Day Low | $12.14 | EPS | $0.00 | |||
| Volume | 3,921,408 | |||||

